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Abstract
β-Glucan and triterpenes are two important derivative compounds from traditional 
medicinal mushroom, such as Ganoderma lucidum and Antrodia cinnamomea. β-glucan 
and triterpenes are considered to have immunoregulatory properties in disease treat-
ment for long years. The immunoregulatory effects are usually activated through some 
transcription of pro-inflammatory genes and possess immunomodulatory activity. 
Difficulty in healing wound now is a common condition that occurred in diabetic 
patients, and the physiological hyperglycemic status of diabetic patients resulting 
in the wounds continue to produce an inflammatory response. Thus, we hope to use 
β-glucan and triterpenes for difficult wound healing that possess immunomodula-
tory activity on the wound micro-environment and stimulate the positive effects on 
healing. In this chapter, these two important derivative compounds from traditional 
medicinal mushroom were examined by diabetic mammal’s wound healing models. In 
these models, the skin wounds’ microenvironment is expected close to diabetic foot, 
suffering in hyperglycemic and inflammatory status. The results are clearly presented, 
with the immunomodulatory effects from mushroom β-glucan and triterpenes that 
involved in modulating the cell-mediated immune system to cause cellular prolifera-
tion and further to introduce healing performance of the chronic inflammation 
wounds.
Keywords: mushroom polysaccharide, β-glucans, triterpenes, immunomodulatory, 
diabetic, wound healing
1. Introduction
Diabetes is a metabolic disease characterized by hyperglycemia resulting from 
defects in insulin secretion or function, and is associated with the long-term dam-
age, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, 
heart, and blood vessels [1]. One of the main consequences of diabetes is the impair-
ment of self-repairing abilities [2]. Various studies have indicated that diets high 
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in saturated fat and cholesterol contribute to hypercholesterolemia and metabolic 
disturbances, which may cause hyperglycemic condition in humans and animals [3]. 
Hyperglycemia can rapidly become severe hyperglycemia and/or ketoacidosis in the 
presence of infection or other types of stress. The inducing stress can result from the 
presence of excessive counter regulatory hormones (glucagon, growth hormone, 
catecholamine, and glucocorticoid; either endogenous or exogenous) and high 
circulating or tissue levels of inflammatory cytokine [1, 4]. As many reports have 
shown, a wound healing is an intricate regulation mechanism, which involves many 
cell populations and molecular mediators, and is one of the key mechanisms that 
ensures the barrier functions of the skin and the maintenance of body homeostasis. 
The efficiency of this process is largely determined by the balance of proinflam-
matory and proregenerative signals, which are mediated by cytokines [5, 6]. But 
in patients who suffer from diabetes mellitus, chronic wounds occur often due to 
the impairment of wound healing; major complications of diabetes lead to inflam-
mation and oxidative stress, delayed wound healing, and persistent ulcers. The 
impaired healing in diabetes is the result of a complex pathophysiology involving 
vascular, neuropathic, immune, and biochemical components. Hyperglycemia cor-
relates with stiffer blood vessels, which cause slower circulation and microvascular 
dysfunction, causing reduced tissue oxygenation. Blood vessel alterations observed 
in diabetic patients also account for reduced leukocyte migration into the wound, 
which becomes more vulnerable to infections. The hyperglycemic environment 
itself can compromise leucocyte function. In addition, peripheral neuropathy can 
lead to numbness of the area and reduced ability to feel pain, which can lead to chro-
nicization of wounds that are not immediately noticed and properly treated [7].
In this chapter, two immunomodulatory extracts (β-glucan and triterpenes) 
from popular medicinal mushroom were assessed by scientific experiments to 
examine the functions for treating poorly healing wounds. These immunomodula-
tory extracts have been studied for its biological effects in mammals widely, and 
reported to possess antitumor and immunomodulating activities with anti-inflam-
matory effects and the ability to control tissue cytokines [8–10]. Here, the scientific 
experiment results of wound healing were consolidated and the novel application 
of derivative compounds from traditional medicinal mushroom can be used for 
treatment of diabetic foot in the future.
2. β-Glucan from mushroom and its diabetic wound caring
2.1 Mushroom β-glucan functions for wound caring
Glucan is a polysaccharide structure which is constructed by D-glucose, linked 
by glycosidic bonds. It is now a common product usually obtained by extracting 
its components from fungi [11] (such as mushrooms) or yeast cell walls and it has 
been known in recent studies to effectively stimulate immune cells; it not only can 
enhance specific immune responses of the organism, but also enhance the nonspe-
cific immune response, and is a good immune regulator. One group of the glucan, 
the beta-glucans (β-glucans), is a heterogeneous group of glucose polymers consist-
ing of β-(1,3)-linked β-d-glucopyranosyl units with a β-(1,6)-linked side chain of 
varying distribution and lengths. These polysaccharides are of different chemical 
compositions, with most belonging to the group of β-glucans; these have β-(1 → 3) 
linkages in the primary chain of the glucan and additional β-(1 → 6) branch points 
that are needed for their bioactive response [12, 13]. Many species of mushroom can 
produce glucan, such as Ganoderma lucidum, Grifola frondosa, Pleurotus ostreatus, 
Lentinula edodes, Cordyceps militaris, and so on [14].
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Research on β-glucans application has indicated that this bioactive immuno-
modulating substance not only enhances the organism’s ability to resist infection by 
bacteria, fungi, viruses, and parasites, but even has the effect of inhibiting tumor 
growth [15]. This novel immunomodulating substance is thought to mediate effects 
through activation of various immune system components including macrophages, 
neutrophils, natural killer (NK) cells, and lymphocytes. Moreover, they are demon-
strated to possess immunostimulatory activity and enhance wound healing espe-
cially by increasing macrophage infiltration into the injury sites and stimulating 
tissue regeneration [16].
In the field of wound healing, it has been pointed out by many related studies 
that by activating macrophages, β-glucan can stimulate the regeneration of collagen 
and help wound healing [17]. In 2001, Kougias and others found that in addition 
to the receptors on immune cells, (1-3)-β-D-glucans receptors were also found 
on human dermal fibroblasts. Making fibroblasts directly receive messages from 
glucans represents a factor that promotes wound healing not only by activating 
macrophages, but also by stimulating fibroblasts [18]. In study of the mechanism 
between fibroblasts and wound healing, we can find that after being stimulated by 
β-glucan, fibroblasts activate two translation factors (transcription factors)-AP-1 
(activator protein-1), SP1 (specific protein-1), and two signaling pathways-NF-κB 
(nuclear factor-κB), NF-1 (nuclear factor-1), can strengthen the immune response 
at the wound site and promote the hyperplasia and the expression of collagen pre-
cursor genes (procollagen genes), thereby generating collagen, to achieve the effect 
of wound healing [18, 19]. The results from a reference illustrated that mushroom 
polysaccharides derived from Schizophyllum (1-3),(1-6)-β-D-glucans, were mixed 
with gelatin to make artificial skin, either by in vitro cell culture or transplanted 
into mice, which led to the observation of the growth of new tissues and finding 
that they all have the effect of promoting epidermal cellization [20]. Mushroom 
β-glucan’s (MBG) role has also been confirmed in tests on the recovery of liver cuts 
in fish and skin wounds in rats. By stimulating the mechanism of Wnt/β catenin sig-
naling signal transmission, liver cell hyperplasia, and cellular activity, it promotes 
wound healing [13]. In the application of β-D-glucans in wound healing, it has a 
reduced chance of infection after surgery [21]; the synthesis of polysaccharides and 
collagen matrix can promote the recovery of local deep scald skin also has a medical 
effect for the relief of patients’ pain [22].
2.2  Mushroom β-glucan (MBG) applied in advanced dressing to promote 
diabetic wound healing (mammal testing model)
In 2018, we carried out a study on mushroom β-glucan (MBG) from G. lucidum 
for testing wound healing in animals. The purified β-glucan of G. lucidum was 
mixed with carboxymethyl cellulose fiber and water, and then through Poly-charge/
ion exchange for compounding, and the composite fiber solution is prepared into 
a fiber sponge substrate by a freeze-drying process, that patented technology from 
Taiwan Textile Research Institute, to form a sponge dressing contain mushroom 
β-glucan (Figure 1(a)). Carboxymethyl cellulose fibers and β-glucan form the 
structure of a sponge, and the mushroom β-glucan-containing particles are evenly 
dispersed in the fiber sponge (Figure 1(b)). The swelling ratio of the fiber sponge 
substrate sample is about 22–32 times. It has the effect of absorbing fluid, which 
means that it can provide the effect of absorbing too much exudate if it is used on 
wounds with a lot of exudate, and maintain the proper moisture of the wound to 
promote wound healing.
The prepared fiber sponge substrate has a high magnification of moisture 
absorption and swelling ratio and an appropriate structural stability that causes the 
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release of mushroom β-glucan (MBG) in the substrate slowly. It is expected that 
it will have an extended-release ability to produce immunostimulatory polysac-
charides, which can improve the shortcomings of commercially available sponge 
dressing products.
In an experiment using three diabetic model pigs, we explored whether mush-
room β-glucan (MBG) sponge dressing can accelerate wound healing rate when 
applied to man-cut wounds. For the present study, all the mammal experiments 
were performed in accordance with protocol by the Institutional Animal Care and 
Use Committee (IACUC) of Agricultural Technology Research Institute (ATRI, in 
Taiwan). Type I diabetes pigs were manual Streptozotocin-induced (to generate 
chronic wound healing), housed, and surgery was operated in SPF animal room 
facilities by ATRI Animal Technology Laboratories. Six square wounds (2 ± 0.5 cm × 2 
± 0.5 cm) with full skin layer on the back of one pig were formed by manual opera-
tion, three on each side, L1, L2, L3 on the left;R1, R2, R3 on the right (schematic dia-
gram in Figure 2), and randomly apply the test mushroom β-glucan (MBG) sponge 
dressing or control dressing to the wound in the above. Then, the wound healing of 
each test substance was continuously observed, and the effect of the test substance 
Figure 1. 
Mushroom β-glucan-containing bio-fiber sponge dressing. (a) Appearance of mushroom β-glucan-containing 
bio-fiber sponge dressing; (b) mushroom β-glucan-containing particles dispersed in the fiber sponge structure 
(1000×).
Figure 2. 
Wounds with full skin layer on the diabetic pig. Six square wounds (2 ± 0.5 cm × 2 ± 0.5 cm) with full skin 
layer on pigs were formed by manual operation, randomly apply the test mushroom β-glucan (MBG) sponge 
dressing or control dressing to the wound in the above (three pigs, each test dressing N = 4 or 5).
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on wound healing was explored based on pathological interpretation. During the test 
period, the test substances in each group did not affect the growth of the pigs and also 
did not cause death.
In data calculation, the average value (mean) and standard error of the 
mean (SEM) of each test group were calculated by Microsoft Excel, and finally 
presented in the report as mean ± SEM. In statistical analysis, one-way ANOVA 
was performed with IBM SPSS Statistics 20 analysis software, and the Scheffe’s 
post-mortem analysis method was used. The lowercase letter labels in figures mean 
that there is a significant difference between those who do not have the same letter 
at the observation time point (p < 0.05). In the experimental results, on the 10th 
day of the experiment, the secretion of tissue fluid of each test group decreased, 
and it was observed that the granulation tissue had grown to fill the entire wound, 
forming a bright red and smooth appearance, and the neonatal epithelial tissue 
could be observed at the edge of the wound, the wound area was significantly 
reduced, for example in Figure 3. The degree of wound healing speed was group B: 
51.1% > group D: 49.2% > group C: 44.3% > group A: 41.0%. In statistical analysis 
results: group A and group B, group A and group C, group A and group D reach 
statistical significance p < 0.05. The statistical significance of group B and C was 
not more than p > 0.05, and the statistical significance of group B and D was not 
more than p > 0.05. Group C and D did not reach statistical significance p > 0.05. 
The test mushroom β-glucan (MBG) sponge dressing showed better wound healing 
performance than vehicle control (Figure 4).
In the histopathological examination result, the thickness of the skin dermal 
layer and epidermal layer were measured to evaluate the wound healing. In the 
Figure 3. 
Ten days’ observation result at the edge of the wound. The performance of wound healing appearance at 10th 
day, the granulation tissue had grown to fill the entire wound, forming a bright red and smooth appearance, 
and the neonatal epithelial tissue could be observed at the edge of the wound.
Figure 4. 
Wound healing ratio.
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diabetic pig model, the thickness of the skin dermal layer of the animals in each test 
group was not different from each other (Figure 5). The analysis of the thickness 
of the epidermal layer showed that the thickness of the test group A is significantly 
higher than that of mushroom β-glucan (MBG) sponge dressing (test group B) 
(p < 0.01) (Figure 6). Epidermal cell layer tissue formation (epithelization) 
showed that the wound healing of each group of animals in the diabetic pig model 
was good, and there was no statistical difference between the test groups in the 
evaluation of epithelial cell formation response (Figure 7).
The results of wound healing tissue react evaluation showed that the inflamma-
tory reaction of animal skin in test group B and test group D was significantly higher 
than that in control group (test group A) with statistical difference (p < 0.01). In 
addition, the degree of inflammatory response stimulation in test group C was 
significantly slowed down compared with the positive control group (test group D), 
indicating that test group B and test group D stimulated local skin inflammation and 
Figure 6. 
The thickness of the epidermal layer of the animals in each test group.
Figure 5. 
The thickness of the skin dermal layer of the animals in each test group.
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accelerated skin wound healing, but significantly slowed down in the experimental 
group C (Figure 8). After assay of the degree of skin blood capillary, the experimen-
tal group B (M1P1 0.5%) can be observed that the response is statistically different 
from the control group (test group A), showing that the new blood capillary of test 
substance is more effective than the control group (test group A) in wound healing 
(Figure 9). Moreover, section slices of recovered wound indicated that mushroom 
β-glucan (MBG) sponge dressing treatment revealed better wound tissue flatness 
effects than untreated group and positive control (Figure 10(a)-(d)).
In conclusion, based on the results of epidermal layer, dermal layer thickness and 
the local tissue reaction of wound healing, the mushroom β-glucan (MBG) sponge 
dressing M1P1 0.5% treatment group (test group B) is more effective in wound 
Figure 7. 
The evaluation of epithelial cell formation response of the animals in each test group.
Figure 8. 
The degree of inflammatory response stimulation of the animals in each test group.
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Figure 10. 
Section slices of recovered wound in each test group. (a) Animal ID: 068-L1 H&E staining, 50×. Group A; (b) 
animal ID: 069-L3 H&E staining, 50×. Group B; (c) animal ID: 070-R1 H&E staining, 50×. Group C; (d) 
animal ID: 069-L2 H&E staining, 50×. Group D. Mushroom β-glucan (MBG) sponge dressing treatment 
(b and c) reveals better wound tissue flatness effects than untreated group and positive control.
Figure 9. 
The degree of skin new blood capillary in each test group.
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healing than the test substance treatment group C (M1P1 1%) and the positive con-
trol group (test group D). When the mushroom β-glucan was applied on diabetic pigs 
wound, we expected the bioactive immunomodulation from mushroom β-glucan 
(MBG) occurred in chronic wound microenvironment, and promote wound healing.
3. Triterpenes from Antrodia cinnamomea in wound caring
3.1 Antrodia cinnamomea triterpenes for wound caring
Since antiquity, mushrooms have been valued by humankind as a culinary 
wonder and folk medicine in Oriental practice. In recent years, mushrooms have 
emerged as a source of dietary supplements, antioxidants, anticancer, prebiotic, 
immunomodulating, anti-inflammatory, cardiovascular, antimicrobial, and 
antidiabetic functions [23]. Among the different types of mushrooms, A. cin-
namomea is a special fungal parasite that grows on the inner cavity of the endemic 
species of Cinnamomum kanehirae (Bull camphor tree) in Taiwan [24]. This 
mushroom is considered as a highly valued mushroom due to its rare occurrence, 
cultivation difficulties of fruit bodies and its common uses as a traditional herb 
for the treatment of several ailments such as diarrhea, abdominal pain, hyperten-
sion, itchy skin, etc. [24, 25]. In Asia, A. cinnamomea dried mycelia powder is 
officially recognized as a rare dietary supplement. Given its popularity, in recent 
years, fermentation techniques have been employed in the mass production of 
A. cinnamomea and its products have been marketed as functional foods for over 
10 years. Among the several bioactive or functional compounds such as polysac-
charides, polysaccharides-peptides, nucleosides, and triterpenes that are reported 
to possess therapeutic effects from A. cinnamomea, bioactive A. cinnamomea 
triterpenes were reported with the activity to possess antitumor and immuno-
modulating activities with anti-inflammatory effects [8], and apoptotic effects in 
the leukemia HL-60 cells, which suggest that the triterpenes extract may possess 
protective antioxidants and anticancer properties for biophysiology [26].
Several plant derivatives, such as secondary metabolites, are capable of promot-
ing wound healing in various animal models. A group of secondary metabolites 
attracting much attention is the pentacyclic triterpenes [27, 28]. Triterpenes, a large 
and structurally diverse group of natural products derived from squalene or related 
acyclic 30-carbon precursors, are uniquely abundant with well-characterized 
biological activities of modulation on the immune cells [29]. In surgical wounds, 
the triterpenes induced a reduction in time to closure, and this effect was reported 
in virtually all wound types. In references, triterpenes also modulate the production 
of ROS in the wound microenvironment, accelerating the process of tissue repair 
through inducing cell migration, cell proliferation, and collagen deposition [27].
According to these findings and hypotheses, we used triterpenes extracted from 
A. cinnamomea mycelium to examine anti-inflammatory responses in STZ-induced 
hyperglycemic mice by oral treatment and observed the effect of triterpenes on 
wound healing model in the mice, and the complete results were published in paper 
in 2016 [30].
3.2  Antrodia cinnamomea triterpenes promote wound healing in hyperglycemic 
diabetic mice model
The A. cinnamomea BCRC36401 was purchased from the Bioresources 
Collection and Research Center (BCRC), Food Industry Research and Development 
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Institute, Hsinchu, Taiwan. In laboratory culture system, the A. cinnamomea was 
subcultured into oats containing 5% glucose (16301, RDH) and 1% yeast extract 
(09182, SIGMA) within the vent plug-glass bottles at 22°C with 12 h of light for 
30 days. After the mycelium was observed to overlap on the cultured oats, the 
mycelia were separated from fermented broth and washed with distilled water. 
Finally, the mycelia were freeze-dried to powders. The freeze-dried powder was 
initiated into the 80°C hot water for 6 h (powder:hot water = 1:100) to separate the 
water-soluble materials. After removal of water-soluble materials, the extraction of 
triterpenes was performed using 99.8% water-free ethanol (SIGMA) (the removed 
water-soluble powder:water-free ethanol = 1:50) in 1.5 h three times, and then 
lyophilized. The extracted compound was used in testing and analysis of triterpenes 
species by HPLC (Figure 11). The A. cinnamomea extract analyzed by HPLC was 
compared to the 11 species of triterpenes and the results was indicated that it was 
including of Antcin H, Dehydrosulphurenic acid, Eburicoic acid, Methyl antcinate 
B and Dehydroeburicoic acid (Table 1). The recovery rate was measured from dif-
ferent weight of the powder and the presented recovery rate about 7–10%.
Diabetes mouse skin wound healing examination was carried out following 
the wound healing model assay procedure [13, 31]. All study procedures were 
performed in accordance with protocol approved by the National Taiwan University 
Animal and Use Committee (NTUAUC). We used 15 of 6-week-old male ICR 
(N = 3, purchased from Laboratory Animal Center, National Taiwan University 
College of Medicine) for this experiment, and animals were housed in the Animal 
Housing Facility of National Taiwan University, College of Life Science. At the 
beginning, manual incision wound (one of 1.5 × 0.5 cm2 full thickness) was 
made on mice skin. Each wound was cleaned by the 3 M Cavilon™ No Rinse-Skin 
Retention time Predicted triterpenes species Height (mAU) Area (mAU × min)
38.59 Antcin H 0.06 0.01
43.01 Dehydrosulphurenic acid, 2.41 0.95
50.50 Eburicoic acid 1.44 0.73
59.65 Methyl antcinate B 2.01 0.65
74.07 Dehydroeburicoic acid 1.22 0.53
Table 1. 
HPLC analyzed results of A. cinnamomea extract in comparison to the purified triterpene standard.
Figure 11. 
HPLC identification of A. cinnamomea extracted triterpenes. (Left) HPLC result of A. cinnamomea 
extract; (right) standard of the 11 species of triterpenes.
11
Novel Application of Immunomodulatory Mushroom Polysaccharide (β-Glucan)…
DOI: http://dx.doi.org/10.5772/intechopen.93122
Cleanser and then sprayed with 3 M Cavilon™ No Sting Barrier Film solution with 
or without A. cinnamomea triterpenes.
Five experiment groups, including: 1. control mice, sprayed with 3 M Cavilon™ 
No Sting Barrier Film, 2. diabetic mice, sprayed with 3 M Cavilon™ No Sting 
Barrier Film, 3. diabetes mice, sprayed with 5 mg/kg triterpenes with 3 M Cavilon™ 
No Sting Barrier Film, 4. diabetic mice sprayed with 10 mg/kg triterpenes with 
3MCavilon™ No Sting Barrier Film, and 5. diabetic mice sprayed with 20 mg/kg 
triterpenes with 3MCavilon™ No Sting Barrier Film. The wound recovery  
assay was observed by area change of wound healing appearance. The surgical 
wound area observation of the five groups was as shown in Figure 12 (on the left).  
Figure 12. 
Long-term observation of the wound healing process. (Left) The performance of wound healing appearance on 
mice; (Right) recovery effectiveness compared to the diabetes group.
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The presented result as shown in the control group (without diabetes), respec-
tively, comparing with the diabetes mice, sprayed with 5, 10, and 20 mg/kg triter-
penes is significantly different in the Days 1–17 after the surgery. In the observation 
of Day 1 to the Day 5, the presented data has shown that the recovery of the 
wounded area is markedly in the control and sprayed with 20 mg/kg triterpenes 
group but not in the diabetes and other treatment groups. In the control group, the 
recovery process is significantly observed in the Day 5 followed the surgery but the 
diabetes group has not shown the wound recovery situation in the Day 5. In the Day 
7 observation, the wound was initiated to be contacted in the control and 20 mg/
kg triterpenes group, other treatment groups were not significant presented with 
recovery especially the diabetes group. The long-term observation of the wound 
healing process can be found that the control group completely healing in the Day 
17. The 20 mg/kg triterpenes group was not completely wound healing (criteria was 
presented as hair totally overlapped on the wound) however, the wound exactly has 
been gradually recovery compared to the diabetes group Figure 12 (right).
In this study, serum biological analysis was also carried out in the five groups. 
After administration of different concentrations of A. cinnamomea triterpenes 
orally, concentrations of serum thrombopoietin (TPO) and CCL1 were measured 
by ELISA. The result showed that diabetes caused an increase in circulating 
thrombopoietin (TPO), but it was found that daily oral administration with 
various concentrations of triterpenes was exactly able to reduce the concentra-
tion of serum TPO. TPO concentration reduced especially in the oral administra-
tion with 10 mg/bw-kg, 20 mg/bw-kg groups and positive control compared 
to the diabetes group from the 3rd week to the end of investigation (p < 0.01) 
(Figure 13). Although, the effect of triterpenes on the reducing CCL1 expression 
Figure 13. 
Serum circulating thrombopoietin (TPO) after administration of different concentrations of A. cinnamomea 
triterpenes orally in diabetic mice.
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was not significant in early observations, on continuous oral administration with 
various concentrations of triterpenes (10 mg/bw-kg, 20 mg/bw-kg and positive 
control), this effect was shown to reduce the serum CCL1 concentration in the 
5th week (p < 0.01) (Figure 14).
As the result, the diabetic mice with skin wound examination, the detection of 
inflammatory factors such as CCL1 and TPO expression were found to induce than 
control mice, the hyperglycemia does cause an inflammatory response. Moreover, to 
the best of our knowledge, hyperglycemia impairs the tissue healing associated with 
an increased and prolonged inflammatory response. An investigation of the anti-
inflammatory response in wound healing as affected by the triterpenes verified the 
promotion of wound recovery.
As the microenvironment of inflammation related to cellular transdifferentia-
tion, migration, proliferation, survival, and extracellular matrix formation. And 
many factors are clearly involved in maintaining the balance between appropriate 
fibroblast activation and the fibrosis resulting from their continued activation 
for wound healing. We suggest the mechanism that the extracted triterpenes may 
bind to the glucocorticoid responsive elements (GREs) of target genes to regulate 
gene expression by mechanisms such as suppressing the expression of proinflam-
matory proteins and enhancing the expression of anti-inflammatory proteins. 
Furthermore, oleanolic acid is a triterpene that can increase insulin secretion by 
activating muscarinic M3 receptors in pancreatic β-cells through the Ach released 
from cholinergic nerve terminals. According to these findings, we suggest that 
the extracted triterpenes from A. cinnamomea may directly permeate the cell to 
bind with the GRE or indirectly combine with the M3 receptor, resulting in an 
anti-inflammatory effect and thereby promoting wound healing in the diabetic 
mice (Figure 15).
Figure 14. 
Serum CCL1 after administration of different concentration A. cinnamomea triterpenes orally in 
diabetic mice.
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4.  A case study of the wound dressing containing mushroom β-glucan 
(MBG) in a type II diabetes mellitus (T2DM) patient with peripheral 
neuropathy
Frequent and uncontrolled hyperglycemic state from type II diabetes mellitus 
(T2DM) can result in peripheral neuropathy in later stages of the disease. Patients 
who suffer from peripheral neuropathy will often suffer from a diabetic foot that 
results directly from peripheral arterial disease (PAD) and/or sensory neuropathy. 
It is a chronic complication of T2DM. If control measures such as infections and 
blood glucose controls are not properly implemented, a diabetic foot can often lead 
to ulcers or gangrene, which eventually result in amputations.
In 2018, a patient who suffered from T2DM volunteered to be included in this 
case study. During the study, as shown in Figure 16a and b, the patient suffered 
from advanced stage of PAD, which resulted in ulcers and gangrenes on the foot’s 
lateral and anterior sides. While the patient followed the primary physician’s 
instructions for lifestyle alteration, routine blood glucose management as well as 
performing a graft surgery for the affected area, under the physician’s discretion, 
Figure 15. 
The proposed mechanism of triterpenes is involved in the diabetic mice with anti-inflammation. Figure 
description: The mechanism of triterpenes was speculated as binding to the glucocorticoid responsive 
elements (GREs) of target genes to regulate gene expression such as by suppressing the expression of 
proinflammatory proteins and enhancing the expression of anti-inflammatory proteins. Furthermore, 
oleanolic acid is a triterpene that can increase insulin secretion by activating muscarinic M3 receptors in 
pancreatic β-cells through the Ach released from cholinergic nerve terminals. According to these findings, 
we suggest that the extracted triterpenes could directly permeate the cell to bind with the GRE or indirectly 
combine with the M3 receptor, resulting in an anti-inflammatory effect and thereby inducing wound healing 
in the diabetic mice.
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a topical test article containing β-glucan isolated from Ganoderma lucidum (MBG) 
and triterpenes purified from A. cinnamomea was applied to the affected site three 
times a day (TID) as a palliative treatment to stimulate wound healing. The heal-
ing progress was recorded weekly and photographs were taken. As results show, 
2 weeks after the test treatment was applied, the wounds showed a significant 
improvement (Figure 16c and d). From week 3 to week 10, the wounds showed 
even more significant improvements and the affected regions were significantly 
reduced (Figure 17). The preliminary results have demonstrated the efficacy of 
a powerful combination of the beta glucan and triterpenes to promote topical 
wound healing, that can inspire further scientific researches and applications of 
such in the future.
Figure 16. 
The severe ulcers on diabetic patient’s feet and treated with β-glucan (MBG) and triterpenes. (a, b) 
Gangrene resulted from peripheral arterial disease and infections. (c, d) After the test article containing 
G. lucidum (Reishi) β-glucan (MBG) and triterpenes purified from A. cinnamomea applied on affected 
area for 2 weeks.
Figure 17. 
A progress for diabetic patient’s feet wound healing. (a–h) The healing progress of gangrenes on a T2DM 
patient’s feet, treated by test article containing G. lucidum (Reishi) β-glucan (MBG) and triterpenes purified 
from A. cinnamomea.
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